Endpoint definition
↥| Name | RX_RHEUMA_BIOLOGICAL |
|---|---|
| Long name | Biological medication for rheuma |
| Medicine purchases: ATC codes | L04AA24|L04AC03|L04AB04|L04AB01|L04AB06|L04AB02|L04AB05|L04AA26|L01XC02|L04AC10|L04AC07|L04AC05 |
| First defined in version | DF5 |
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1802 | 1102 | 700 |
| Unadjusted prevalence (%) | 0.83 | 0.90 | 0.74 |
| Mean age at first event (years) | 47.58 | 47.33 | 47.98 |
| Case fatality at 5-years (%) | 0.67 | 0.54 | 0.86 |
Longitudinal metrics
| All | Female | Male | |
|---|---|---|---|
| Median nb. of events per indiv. | 15.0 | 14.0 | 15.0 |
| Recurrence at 6 months (%) | 94.14 | 93.58 | 95.03 |
Survival analyses between endpoints
↥Plot
before Biological medication for rheuma
after Biological medication for rheuma
Loading survival analyses plot…
Table
Loading survival analyses table…